Text Size

Treatment of Open-Angle Glaucoma and Ocular Hypertension with Preservative-Free Tafluprost/Timolol Fixed-Dose Combination Therapy: Results from the VISIONARY Study Population in Spain.

Garcia-Medina, J. J.; Benitez-Del-Castillo, J.; Rodríguez-Agirretxe, I.; Lopez-Lopez, F.; Moreno-Valladares, A.


  • 2022
  • Journal of Ocular Pharmacology and Therapeutics
View publication
  • Therapeutic Area

    Glaucoma

  • Categories

    Clinical development

  • Affiliations

    Department of Ophthalmology, Hospital General Universitario Morales Meseguer, Murcia, Spain; Department of Ophthalmology, Hospital Universitario de Jerez, Jerez de la Frontera Cadiz, Spain; Department of Ophthalmology, Hospital Universitario Donostia, San Sebastian Guipuzcoa, Spain; Instituto Oftalmológico Gomez-Ulla, Santiago de Compostela Galicia, Spain; Department of Ophthalmology, Complejo Hospitalario Universitario de Albacete, Albacete, Spain

Related Publications

Long-term safety and efficacy of sepetaprost, with or without timolol, in patients with open-angle glaucoma or ocular hypertension: results from the randomised, phase 3 ANGEL-J2 study

Inatani M., Tone Y., Ikeda T., Angeles R.


Efficacy and safety of sepetaprost in patients with primary open-angle glaucoma or ocular hypertension: results from the randomised, phase 3 ANGEL-J1 study

Inatani M., Kanamori A., Inai M., Ikeda T., Angeles R.


Clinical outcomes of Preserflo MicroShunt implant procedure in open‑angle glaucoma patients – a 1000 eyes case-series; including subanalysis of combined cataract-glaucoma surgery and standalone surgery in pseudophakic eyes

Klabe, K.; Werth, J.P.; Kaymak, H. ; Fricke, A.


Can't find what you're looking for?

Contact us

Document number: NP-No product-EMEA-0110
Date of preparation: February 2022